Painting a new picture of personalised medicine for diabetes

Diabetologia

Volumn 60, Issue 5, 2017, Pages 793-799

  McCarthy, Mark I ^a,b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Biomarkers; Complex disease; Diabetes; Environment; Genetics; Pathogenesis; Review; Risk; Taxonomy

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; C REACTIVE PROTEIN; INSULIN;

ALLELE; DIABETES MELLITUS; DISEASE COURSE; DNA SEQUENCE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENETIC RISK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; BLOOD; GENETICS; GENOMICS; METABOLISM; PATHOLOGY; PROCEDURES;

BIOMARKERS; DIABETES MELLITUS, TYPE 2; GENOMICS; HUMANS; PRECISION MEDICINE;

EID: 85011845576     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-017-4210-x     Document Type: Review

References (22)

1. International Statistical Classification of Diseases and Related Health Problems 10th Revision (2010) http://apps.who.int/classifications/icd10/browse/2010/en. Accessed 10 Nov 2016
2. Frank LL (1957) Diabetes mellitus in the texts of old Hindu medicine (Charaka, Susruta, Vagbhata). Am J Gastroenterol 27:76–95
3. Auffray C, Charron D, Hood L (2010) Predictive, preventive, personalized and participatory medicine: back to the future. Genome Med 2:57
4. Ashley EA (2016) Towards precision medicine. Nat Rev Genet 17:507–522
5. Fuchsberger C, Flannick J, Teslovich TM et al (2016) The genetic architecture of type 2 diabetes. Nature 536:41–47
6. Franks PW, McCarthy MI (2016) Exposing the exposures responsible for type 2 diabetes and obesity. Science 354:69–73
7. Owen KR (2016) Treating young adults with type 2 diabetes or monogenic diabetes. Best Pract Res Clin Endocrinol Metab 30:455–467
8. Nogueira TC, Paula FM, Villate O et al (2013) GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim. PLoS Genet 9, e1003532
9. Cervin C, Lyssenko V, Bakhtadze E et al (2008) Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 57:1433–1437
10. Østergaard JA, Laugesen E, Leslie RD (2016) Should there be concern about autoimmune diabetes in adults? Current evidence and controversies. Curr Diab Rep 16:82
11. Flannick J, Beer NL, Bick AG et al (2013) Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes. Nat Genet 45:1380–1385
12. Shields BM, McDonald TJ, Ellard S, Campbell MJ, Hyde C, Hattersley AT (2012) The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia 55:1265–1272
13. Schwartz SS, Epstein S, Corkey BE, Grant SF, Gavin JR 3rd, Aguilar RB (2016) The time is right for a new classification system for diabetes: rationale and implications of the β-cell-centric classification schema. Diabetes Care 39:179–186
14. Gale EAM (2006) Declassifying diabetes. Diabetologia 49:1989–1995
15. Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579–589
16. Dimas AS, Lagou V, Barker A et al (2014) Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63:2158–2171
17. Gaulton KJ, Ferreira T, Lee Y et al (2015) Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet 47:1415–1425
18. Small KS, Hedman AK, Grundberg E et al (2011) Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat Genet 43:561–564
19. Besser RE, Shields BM, Hammersley SE et al (2013) Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes. Pediatr Diabetes 14:181–188
20. Thanabalasingham G, Shah N, Vaxillaire M et al (2011) A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia 54:2801–2810
21. Zeevi D, Korem T, Zmora N et al (2015) Personalized nutrition by prediction of glycemic responses. Cell 163:1079–1094
22. Li L, Cheng W-Y, Glicksberg BS et al (2015) Identification of type 2 diabetes subgroups through topological analysis of patient similarity. Sci Transl Med 7:311ra174